16-2071623-G-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000548.5(TSC2):​c.1946+7G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

TSC2
NM_000548.5 splice_region, intron

Scores

2
Splicing: ADA: 0.0002530
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.540

Publications

1 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 16-2071623-G-A is Benign according to our data. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2071623-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 379713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 36 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC2NM_000548.5 linkc.1946+7G>A splice_region_variant, intron_variant Intron 18 of 41 ENST00000219476.9 NP_000539.2 P49815-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC2ENST00000219476.9 linkc.1946+7G>A splice_region_variant, intron_variant Intron 18 of 41 5 NM_000548.5 ENSP00000219476.3 P49815-1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152228
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000561
AC:
14
AN:
249428
AF XY:
0.0000665
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000232
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000267
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.0000246
AC:
36
AN:
1460896
Hom.:
0
Cov.:
32
AF XY:
0.0000248
AC XY:
18
AN XY:
726750
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.000291
AC:
13
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86226
European-Finnish (FIN)
AF:
0.0000190
AC:
1
AN:
52556
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1111960
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152228
Hom.:
0
Cov.:
33
AF XY:
0.0000403
AC XY:
3
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41458
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000869
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Tuberous sclerosis 2 Benign:3
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 09, 2024
Myriad Genetics, Inc.
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. -

not specified Benign:1
Dec 08, 2016
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
5.8
DANN
Benign
0.41
PhyloP100
0.54
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00025
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759576009; hg19: chr16-2121624; API